Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AMATINE DIN 01934406

Status: Cancelled Post Market
Holder: SHIRE PHARMA CANADA ULC
Molecule: MIDODRINE HYDROCHLORIDE

Health Canada record

Active ingredient(s)MIDODRINE HYDROCHLORIDE 5 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCC01CA17 MIDODRINE
Original market date31-Dec-1992
Current status date04-Oct-2010
SourceHealth Canada DPD

Establishment licence of the holder

Shire Pharma Canada ULC — licence 100314, not currently licensed, last inspection rating C (2017-08-22).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MIDODRINE HYDROCHLORIDE

DINProductCompanyFormStrengthStatus
02278677APO-MIDODRINEAPOTEX INCTabletMIDODRINE HYDROCHLORIDE 2.5 MGMarketed
02278685APO-MIDODRINEAPOTEX INCTabletMIDODRINE HYDROCHLORIDE 5 MGMarketed
02517701JAMP MIDODRINEJAMP PHARMA CORPORATIONTabletMIDODRINE HYDROCHLORIDE 2.5 MGMarketed
02517728JAMP MIDODRINEJAMP PHARMA CORPORATIONTabletMIDODRINE HYDROCHLORIDE 5 MGMarketed
02547120M-MIDODRINEMANTRA PHARMA INCTabletMIDODRINE HYDROCHLORIDE 5 MGMarketed
02547112M-MIDODRINEMANTRA PHARMA INCTabletMIDODRINE HYDROCHLORIDE 2.5 MGMarketed
02473984MAR-MIDODRINEMARCAN PHARMACEUTICALS INCTabletMIDODRINE HYDROCHLORIDE 2.5 MGMarketed
02473992MAR-MIDODRINEMARCAN PHARMACEUTICALS INCTabletMIDODRINE HYDROCHLORIDE 5 MGMarketed
02533200MIDODRINESANIS HEALTH INCTabletMIDODRINE HYDROCHLORIDE 2.5 MGMarketed
02533219MIDODRINESANIS HEALTH INCTabletMIDODRINE HYDROCHLORIDE 5 MGMarketed
01934392AMATINESHIRE PHARMA CANADA ULCTabletMIDODRINE HYDROCHLORIDE 2.5 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
94662008-04-03New Drug Submission (NDS)MANUFACTURER NAME CHANGE
27322003-07-21New Drug Submission (NDS)
13282000-02-24New Drug Submission (NDS)

International API supply for MIDODRINE HYDROCHLORIDE

14 active FDA Drug Master Files.

Request a quote for AMATINE

How to read a Canadian DIN record